Unknown PHASE3 INTERVENTIONAL 2-arm NCT04791202

Hypertonic Dextrose Versus Corticosteroid Intra-Articular Injections for the Treatment of Trapeziometacarpal Arthritis

Hypertonic Dextrose Versus Corticosteroid Intra-Articular Injections for the Treatment of Trapeziometacarpal Arthritis: A Prospective Double-blind Randomized Controlled Clinical Trial

Sponsor: Christine M. Kleinert Institute for Hand and Microsurgery

Conditions Functionality Pain Satisfaction, Patient

Interventions Dextrose Methylprednisolone Acetate 40 MG/ML

Updated 4 times since 2021 Last updated: Mar 12, 2021 Started: Apr 1, 2021 Primary completion: Mar 1, 2022 Completion: Jul 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Functionality and Pain, this trial is ongoing. The trial is conducted by Christine M. Kleinert Institute for Hand and Microsurgery and has accumulated 4 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Apr 2023 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Not Yet Recruiting → Unknown Status
Apr 2021 — Apr 2023 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Christine M. Kleinert Institute for Hand and Microsurgery
Kleinert, Kutz and Associates

Data source: Christine M. Kleinert Institute for Hand and Microsurgery

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.